Fancy Your Chances?
Intracameral antibiotics reduce the risk of cataract complications – so why aren’t we using them?
John Berdahl |
Cataract surgery is the most common ophthalmological procedure in the world. And like all procedures, it has some risks – the worst being endophthalmitis. Endophthalmitis affects between 0.13 percent and 0.7 percent of patients (1) and can have devastating consequences, with some losing light perception all together. So what can we do about it?
The answer is intracameral antibiotics. In my mind, they’re one of the most important innovations in modern ophthalmology. Several studies have shown that intracameral antibiotics unequivocally decrease the incidence of endophthalmitis. But we’re not using them in the US.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.